Johnson Johnson and MapleMerger Sub Inc

Singh earlier this month accused Pakistan of acting irresponsibly, and said the Mumbai attacks must have had support from some of its official agencies. Pakistan has rejected the accusation and said such charges jeopardised chances of cooperation against terrorism. INTERNATIONAL COMMUNITY Tensions have run high between the two nuclear-armed rivals since the attack that India has blamed on the Pakistani militant group Lashkar-e-Taiba, with India increasingly frustrated with what it sees as Pakistan's tardiness in responding. Urging Pakistan to show that it is sincere "through its actions" as well, Singh said Pakistan should act against LeT and other militant groups "in its own interest" as well, and called on the international community to exert pressure on Pakistan.

"We expect the international community to use its full weight to see that the investigations are pursued to a speedy and logical conclusion and terrorist groups operating from Pakistan are completely shut down," Singh said. Pakistan, in turn, has been angered by the Indian suggestion that Pakistani state agencies were involved and what it sees as repeated Indian hints of military action. But the chances of a military confrontation between the two rivals that have fought three wars since 1947 have receded, according to analysts, thanks in part due to the diplomacy of the United States and other powers.. Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with92.9 of Shares Tendered- Johnson & Johnson Will Commence Subsequent Offering Period NEW BRUNSWICK, N.J., Jan. 17 /PRNewswire-FirstCall/ Johnson & Johnson(NYSE: JNJ) today announced that the initial tender offer, through its whollyowned subsidiary, Maple Merger Sub, Inc., for all outstanding shares of commonstock of Mentor Corporation (NYSE: MNT) expired at 5:00 PM (Eastern time) onJan. 16, 2009, and was not extended.The depositary for the tender offer has advised Johnson & Johnson that, as ofthe expiration of the initial tender offer, a total of approximately31,456,557 shares of Mentor common stock were validly tendered and notwithdrawn (including approximately 4,632,228 shares subject to guaranteeddelivery procedures), representing approximately 92.9 of the outstandingshares of Mentor common stock.All shares that were validly tendered and notproperly withdrawn during the initial offering period have been accepted forpayment.Johnson & Johnson also announced that it will commence through Maple MergerSub, Inc., a subsequent offering period to acquire all remaining shares ofMentor common stock, which will begin on Tuesday, Jan 20, 2009 and expire at12:00 midnight (Eastern time) on Jan.

22, 2009, unless extended.Any sharesvalidly tendered during the subsequent offering period will be immediatelyaccepted for payment, and tendering shareholders will promptly thereafter bepaid $31.00 per share, less any required withholding taxes, in cash andwithout interest, which is the same amount per share that was offered and paidin the initial offering period.The subsequent offering period enablesholders of shares of Mentor common stock who did not tender during the initialoffering period to participate in the offer and receive the offer price on anexpedited basis rather than waiting until the completion of the mergerdescribed below.Shares tendered during the subsequent offering period cannotbe delivered by the guaranteed delivery procedure and may not be withdrawn. In addition, shares validly tendered during the initial offering period maynot be withdrawn during the subsequent offering period. If, following the expiration of the subsequent offering period, Maple MergerSub, Inc. owns at least 90 of the shares of Mentor common stock outstanding,the merger will be completed through what is known as a "short-form merger"without a vote or meeting of Mentor's remaining shareholders. Upon closing, the transaction is expected to have a dilutive impact to Johnson& Johnson's 2009 earnings per share of approximately $.03 - $.05.This amountwill be reflected as part of Johnson & Johnson's earnings guidance, which willbe provided on Jan. We embrace research and science bringing innovativeideas, products and services to advance the health and well-being of people.Our 119,400 employees at more than 250 Johnson & Johnson companies work withpartners in health care to touch the lives of over a billion people every day,throughout the world.Additional InformationThis press release is neither an offer to purchase nor a solicitation of anoffer to sell shares of Mentor Corporation.Johnson & Johnson and MapleMerger Sub, Inc. have filed a tender offer statement with the Securities andExchange Commission ("SEC"), and have mailed an offer to purchase, forms ofletter of transmittal and related documents to Mentor shareholders.Mentorhas filed with the SEC, and has mailed to Mentor shareholders, asolicitation/recommendation statement on Schedule 14D-9.